RecruitingNot ApplicableNCT04472156
A Prospective Study of a Mosaic Embryo Transfer
Sponsor
Colorado Center for Reproductive Medicine
Enrollment
250 participants
Start Date
Oct 15, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
This research is a prospective study in which the purpose is to investigate the clinical outcomes following the transfer of a mosaic embryo (presence of both chromosomally normal and abnormal cells) that has been screened for preimplantation genetic testing (PGT).
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years
Inclusion Criteria3
- Women age 18-45 Infertile women who have completed an IVF cycle with PGT at the Colorado Center for Reproductive Medicine (CCRM) that have a mosaic embryo
- Patients can be of any race, culture, sexual orientation or ethnicity
- Patients that are willing to transfer a single embryo
Exclusion Criteria5
- Patients that do not meet the clinical requirements for an embryo transfer per clinic standards.
- Patients that desire more than a single embryo transfer.
- Patients that are using a gestational carrier.
- Embryonic mosaic PGT results that include chromosome errors 13, 18, 21
- Patients that did not complete their IVF with PGT cycle at the Colorado Center for Reproductive Medicine.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURETransfer of mosaic embryo
Subjects will transfer a mosaic embryo transferred to their uterus
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04472156
Related Trials
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
NCT054406171 location
Inherited Reproductive Disorders
NCT015004472 locations
The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study
NCT072263101 location
Aromatherapy for Mental Health Promotion in IVF Patients
NCT074806681 location
AI-TOP Study Artificial Intelligence for Trigger Optimization.
NCT075151185 locations